
Lymphoma Risk in RA Patients Remains Steady

Fellows’ Forum Case Report: Hemophagocytic Lymphohistiocytosis
Malignancy Risk in ANCA-Associated Vasculitis Is Lower with Rituximab
Tofacitinib Not Tied to More Malignancies in RA Patients

• By Reuters Staff
• By Kurt Ullman
• By Anita Laloo, MB, BS, MPH, German Pihan, MD, & Robert H. Shmerling, MD
• By Marilynn Larkin
• By David Douglas
• By Susan Bernstein
Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.
The Foundation is the largest private funding source for rheumatology research and training in the U.S.
Visit the official website for the American College of Rheumatology.